Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9386006 | Respiratory Medicine | 2005 | 8 Pages |
Abstract
Conclusions: Three months of oral clarithromycin given to subjects with stable COPD does not improve health status, sputum bacterial numbers or exacerbation rate. Treatment of COPD with clarithromycin during the clinical stable state yields no clinical advantages and therefore cannot be recommended as means of eliminating sputum bacteria or preventing infective exacerbations.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
D. Banerjee, O.A. Khair, D. Honeybourne,